Rifamycin antibiotics in chronic bronchitis. 1970

K M Citron, and J R May

UI MeSH Term Description Entries
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

K M Citron, and J R May
December 1969, Lancet (London, England),
K M Citron, and J R May
October 1953, Lancet (London, England),
K M Citron, and J R May
December 1979, Vnitrni lekarstvi,
K M Citron, and J R May
November 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K M Citron, and J R May
August 1980, The Medical letter on drugs and therapeutics,
K M Citron, and J R May
December 1965, Belgisch tijdschrift voor geneeskunde,
K M Citron, and J R May
December 1963, British medical journal,
K M Citron, and J R May
January 1983, Annals of internal medicine,
K M Citron, and J R May
December 1957, The Practitioner,
K M Citron, and J R May
December 1964, The Practitioner,
Copied contents to your clipboard!